All In MedTech

Device Trial Radar · NCT01175928

Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy

Phase 2 Study of the NormaTec PCD in the Treatment of Diabetic Peripheral Neuropathy

Last checked: Nov 20, 2026Latest source record: Apr 20, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Oct 2010

Primary completion

Sep 2012

Study completion Sep 2012

Sponsor

Lead sponsor
NormaTec Industries LPNot on our public-company list
Sponsor type
Industry
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Aug 5, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of the NormaTec PCD, a non-invasive pneumatic compression device with the patented peristaltic pulse pneumatic waveform, in the treatment of Diabetic Peripheral Neuropathy (DPN). The study will compare treatment with a NormaTec PCD and a sham device to assess whether the NormaTec PCD improves the signs and symptoms of DPN.

Conditions

  • Diabetic Polyneuropathy

Interventions

  • Sham deviceDevice

    Home treatment with PCD to both legs: 2 sessions of 1 hour duration every day

  • NormaTec PCD (Peristaltic Pulse PCD)Device

    Home treatment with PCD to both legs: 2 sessions of 1 hour duration every day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Nerve Conduction StudiesTime frame: 3 months

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • NormaTec

    Newton Center, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.